Category: MassDevice.com Earnings RoundupSyndicate content

Stryker edges The Street despite plunging Q3 profits

October 16, 2014 by Brad Perriello

Stryker edges expectations on Wall Street despite a nearly 45% profit slide as it posts strong revenue growth and expands its footprint in Europe.

Stryker edges The Street despite plunging Q3 profits

Investors eye 3rd-quarter medical use from hospitals, insurers

October 16, 2014 by MassDevice

Investors eye 3rd-quarter data for evidence that Obamacare is driving an increase in procedure volumes.

Investors eye 3rd-quarter medical use from hospitals, insurers

(Reuters) – Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, according to investors who are closely watching U.S. medical services use.

Getinge trims sales forecast as Q3 falls short

October 16, 2014 by MassDevice

Getinge lowers its sales forecast for the rest of the year amid uncertain earnings outlook, sending share prices plunging in Stockholm.

Getinge trims sales forecast as Q3 falls short

St. Jude Medical CEO: CardioMEMS the 'single most important new growth driver'

October 16, 2014 by Brian Johnson

St. Jude Medical CEO Dan Starks is bullish on the potential for recent acquisition CardioMEMS to tap the $1 billion market for treating heart failure.


St. Jude Medical CEO: CardioMEMS the 'single most important new growth driver' in portfolio

Medical products push Baxter profit above estimate

October 16, 2014 by MassDevice

Baxter's 3rd-quarter profits beat expectations, driven by its medical product business, but shares slide on a lowered earnings forecast.

Medical products push Baxter profit above estimate

(Reuters) - Medical device and drug maker Baxter (NYSE:BAX) reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

St. Jude Medical's adjusted profit rises

October 15, 2014 by MassDevice

St. Jude Medical's adjusted profits rise during the 3rd quarter as the company narrows its earnings guidance and lowers its sales outlook.

St. Jude Medical's adjusted profit rises

J&J sales top forecast, helped by hepatitis drug

October 14, 2014 by MassDevice

Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.

J&J sales top forecast, helped by hepatitis drug
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp